IR
Superintel
Overview
Markets
Watchlist
More
Ascendis Pharma A/S
CUSIP: 04351P951 | 9 institutional holders
Watch
Quarters
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile